Inter- and intraobserver agreement of the quantitative assessment of [99mTc]-labelled anti-programmed death-ligand 1 (PD-L1) SPECT/CT in non-small cell lung cancer.
Daniel Johnathan HughesGitasha ChandVicky J GohGary J R CookPublished in: EJNMMI research (2020)
ClinicalTrials.gov identifier no. NCT02978196. Registered 30th November 2016.